Research ArticleConference Proceedings

Device Cleaning and Infection Control in Aerosol Therapy

Catherine A O'Malley
Respiratory Care June 2015, 60 (6) 917-930; DOI: https://doi.org/10.4187/respcare.03513

References

  1. 1.↵
    1. Rutala WA,
    2. Weber DJ
    , Healthcare Infection Control Practices Advisory Committee (HICPAC). Guideline for disinfection and sterilization in healthcare facilities, 2008. http://www.cdc.gov/hicpac/pdf/guidelines/disinfection_nov_2008.pdf. Accessed February 12, 2015.
  2. 2.↵
    1. Saiman L,
    2. Siegel J
    , Cystic Fibrosis Foundation. Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission. Infect Control Hosp Epidemiol 2003;24(5 Suppl):S6-S52.
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    1. Lester MK,
    2. Flume PA,
    3. Gray SL,
    4. Anderson D,
    5. Bowman CM
    . Nebulizer use and maintenance by cystic fibrosis patients: a survey study. Respir Care 2004;49(12):1504-1508.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. O'Malley CA,
    2. VandenBranden SL,
    3. Zheng XT,
    4. Polito AM,
    5. McColley SA
    . A day in the life of a nebulizer: surveillance for bacterial growth in nebulizer equipment of children with cystic fibrosis in the hospital setting. Respir Care 2007;52(3):258-262.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Garber E,
    2. Desai M,
    3. Zhou J,
    4. Alba L,
    5. Angst D,
    6. Cabana M,
    7. et al
    . Barriers to adherence to cystic fibrosis infection control guidelines. Pediatr Pulmonol 2008;43(9):900-907.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Lugtenberg M,
    2. Zegers-van Schaick JM,
    3. Westert GP,
    4. Burgers JS
    . Why don't physicians adhere to guideline recommendations in practice? An analysis of barriers among Dutch general practitioners. Implement Sci 2009;4:54.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Savant AP,
    2. O'Malley C,
    3. Bichl S,
    4. McColley SA
    . Improved patient safety through reduced airway infection rates in a paediatric cystic fibrosis programme after a quality improvement effort and infection prevention and control measures. BMJ Qual Saf 2014;23(Suppl 1):i73-i80.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Hutchinson GR,
    2. Parker S,
    3. Pryor JA,
    4. Duncan-Skingle F,
    5. Hoffman PN,
    6. Hodson ME,
    7. et al
    . Home-use nebulizers: a potential primary source of Burkholderia cepacia and other colistin-resistant, Gram-negative bacteria in patients with cystic fibrosis. J Clin Microbiol 1996;34(3):584-587.
    OpenUrlAbstract/FREE Full Text
  9. 9.
    1. Pitchford KC,
    2. Corey M,
    3. Highsmith AK,
    4. Perlman R,
    5. Bannatyne R,
    6. Gold R,
    7. et al
    . Pseudomonas species contamination of cystic fibrosis patients' home inhalation equipment. J Pediatr 1987;111(2):212-216.
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.
    1. Rosenfeld M,
    2. Joy P,
    3. Nguyen CD,
    4. Krzewinski J,
    5. Burns JL
    . Cleaning home nebulizers used by patients with cystic fibrosis: is rinsing with tap water enough? J Hosp Infect 2001;49(3):229-230.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Jakobsson BM,
    2. Onnered AB,
    3. Hjelte L,
    4. Nyström B
    . Low bacterial contamination of nebulizers in home treatment of cystic fibrosis patients. J Hosp Infect 1997;36(3):201-207.
    OpenUrlCrossRefPubMedWeb of Science
  12. 12.↵
    1. Hamill RJ,
    2. Houston ED,
    3. Georghiou PR,
    4. Wright CE,
    5. Koza MA,
    6. Cadle RM,
    7. et al
    . An outbreak of Burkholderia (formerly Pseudomonas) cepacia respiratory tract colonization and infection associated with nebulized albuterol therapy. Ann Intern Med 1995;122(10):762-766.
    OpenUrlPubMedWeb of Science
  13. 13.
    1. Sanders CV Jr.,
    2. Luby JP,
    3. Johanson WG Jr.,
    4. Barnett JA,
    5. Sanford JP
    . Serratia marcescens infections from inhalation therapy medications: nosocomial outbreak. Ann Intern Med 1970;73(1):15-21.
    OpenUrlCrossRefPubMedWeb of Science
  14. 14.↵
    1. Ramsey AH,
    2. Skonieczny P,
    3. Coolidge DT,
    4. Kurzynski TA,
    5. Proctor ME,
    6. Davis JP
    . Burkholderia cepacia lower respiratory tract infection associated with exposure to a respiratory therapist. Infect Control Hosp Epidemiol. 2001;22(7):423-426.
    OpenUrlCrossRefPubMedWeb of Science
  15. 15.↵
    1. Vassal S,
    2. Taamma R,
    3. Marty N,
    4. Sardet A,
    5. d'Athis P,
    6. Brémont F,
    7. et al
    . Microbiologic contamination study of nebulizers after aerosol therapy in patients with cystic fibrosis. Am J Infect Control 2000;28(5):347-351.
    OpenUrlCrossRefPubMedWeb of Science
  16. 16.↵
    1. Cobben NA,
    2. Drent M,
    3. Jonkers M,
    4. Wouters EF,
    5. Vaneechoutte M,
    6. Stobberingh EE
    . Outbreak of severe Pseudomonas aeruginosa respiratory infections due to contaminated nebulizers. J Hosp Infect 1996;33(1):63-70.
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.↵
    1. Tablan OC,
    2. Anderson LJ,
    3. Besser R,
    4. Bridges C,
    5. Hajjeh R
    , CDC, Healthcare Infection Control Practices Advisory Committee. Guidelines for preventing health care-associated pneumonia 2003: recommendations of the CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep 2004;53(RR-3):1-36.
    OpenUrlPubMed
  18. 18.↵
    1. Craven DE,
    2. Lichtenberg DA,
    3. Goularte TA,
    4. Make BJ,
    5. McCabe WR
    . Contaminated medication nebulizers in mechanical ventilation circuits. Source of bacterial aerosols. Am J Med 1984;77(5):834-838.
    OpenUrlCrossRefPubMedWeb of Science
  19. 19.
    1. Mastro TD,
    2. Fields BS,
    3. Breiman RF,
    4. Campbell J,
    5. Plikaytis BD,
    6. Spika JS
    . Nosocomial Legionnaires' disease and use of medication nebulizers. J Infect Dis 1991;163(3):667-671.
    OpenUrlAbstract/FREE Full Text
  20. 20.↵
    1. Reboli AC,
    2. Koshinski R,
    3. Arias K,
    4. Marks-Austin K,
    5. Stieritz D,
    6. Stull TL
    . An outbreak of Burkholderia cepacia lower respiratory tract infection associated with contaminated albuterol nebulization solution. Infect Control Hosp Epidemiol 1996;17(11):741-743.
    OpenUrlPubMedWeb of Science
  21. 21.↵
    Healthcare Infection Control Practices Advisory Committee, Centers for Disease Control and Prevention (U.S.). Guidelines for preventing health-care-associated pneumonia, 2003 recommendations of the CDC and the Healthcare Infection Control Practices Advisory Committee. Respir Care 2004;49(8):926-939.
    OpenUrlFREE Full Text
  22. 22.↵
    Centers for Disease Control and Prevention. Guideline for prevention of nosocomial pneumonia. Respir Care 1994;39(12):1191-1236.
    OpenUrlPubMed
  23. 23.↵
    1. Hess DR
    . Guidelines for preventing health-care associated pneumonia, 2003: buyer beware! Respir Care 2004;49(8):891-893.
    OpenUrlFREE Full Text
  24. 24.↵
    1. Ari A,
    2. Restrepo RD
    , American Association for Respiratory Care. Aerosol delivery device selection for spontaneously breathing patients: 2012. Respir Care 2012;57(4):613-626.
    OpenUrlAbstract/FREE Full Text
  25. 25.↵
    1. Standaert TA,
    2. Morlin GL,
    3. Williams-Warren J,
    4. Joy P,
    5. Pepe MS,
    6. Weber A,
    7. Ramsey BW
    . Effects of repetitive use and cleaning techniques of disposable jet nebulizers on aerosol generation. Chest 1998;114(2):577-586.
    OpenUrlCrossRefPubMed
  26. 26.↵
    1. Weber DJ,
    2. Rutala WA,
    3. Sickbert-Bennett EE
    . Outbreaks associated with contaminated antiseptics and disinfectants. Antimicrob Agents Chemother 2007;51(12):4217-4224.
    OpenUrlFREE Full Text
  27. 27.↵
    1. Carrico R
    1. Friedman C
    . Infection prevention and control programs. In: Carrico R. APIC text of infection control and epidemiology, 2011. http://text.apic.org/item-2/chapter-1-infection-prevention-and-control-programs/basic-principles. Accessed March 20, 2014.
  28. 28.↵
    1. Saiman L,
    2. Siegel JD,
    3. LiPuma JL,
    4. Brown RF,
    5. Bryson EA,
    6. Chambers MJ,
    7. et al
    . Infection prevention and control guideline for cystic fibrosis: 2013 update. Infect Control Hosp Epidemiol 2014;35(Suppl 1):S1-S67.
    OpenUrlPubMed
  29. 29.↵
    1. Neel S,
    2. Tauman A
    . Can successful implementation of the common canister program deliver cost containment and improved infection control? Hosp Pharm 2012;47(9):700-711.
    OpenUrl
  30. 30.↵
    1. Hess DR
    . Aerosol delivery devices in the treatment of asthma. Respir Care 2008;53(6):699-723; discussion 723-725.
    OpenUrlAbstract/FREE Full Text
  31. 31.↵
    1. Cohen HA,
    2. Cohen Z,
    3. Pomeranz AS,
    4. Czitron B,
    5. Kahan E
    . Bacterial contamination of spacer devices used by asthmatic children. J Asthma 2005;42(3):169-172.
    OpenUrlPubMedWeb of Science
  32. 32.↵
    1. Mitchell JP,
    2. Coppolo DP,
    3. Nagel MW
    . Electrostatics and inhaled medications: influence on delivery via pressurized metered-dose inhalers and add-on devices. Respir Care 2007;52(3):283-300.
    OpenUrlAbstract/FREE Full Text
  33. 33.↵
    1. Piérart F,
    2. Wildhaber JH,
    3. Vrancken I,
    4. Devadason SG,
    5. Le Souëf PN
    . Washing plastic spacers in household detergent reduces electrostatic charge and greatly improves delivery. Eur Respir J 1999;13(3):673-678.
    OpenUrlAbstract
  34. 34.↵
    1. Slader CA,
    2. Reddel HK,
    3. Bosnic-Anticevich SZ
    . Lack of awareness of need to clean CFC-free metered-dose inhalers. J Asthma 2004;41(3):367-373.
    OpenUrlPubMed
  35. 35.↵
    1. Bamber MG
    . Difficulties with CFC-free salbutamol inhaler. Lancet 1996;348(9043):1737.
    OpenUrlPubMedWeb of Science
  36. 36.↵
    1. Mabbott FA,
    2. Mullen AB,
    3. Smith A,
    4. Smith G,
    5. Boyter AC
    . Qualitative analysis of microbial contamination of inhalers. J Hosp Infect 2011;77(3):277-278.
    OpenUrlPubMed
  37. 37.↵
    1. Krueger-Parkinson R
    . Right language. The challenge to improve health literacy: what RTs need to know to communicate effectively with patients. AARC Times 2005;29(5):41-43.
    OpenUrl
  38. 38.↵
    1. Davis TC,
    2. Mayeaux EJ,
    3. Fredrickson D,
    4. Bocchini JA Jr.,
    5. Jackson RH,
    6. Murphy PW
    . Reading ability of parents compared with reading level of pediatric patient education materials. Pediatrics 1994;93(3):460-468.
    OpenUrlAbstract/FREE Full Text
  39. 39.↵
    1. Fink JB,
    2. Rubin BK
    . Problems with inhaler use: a call for improved clinician and patient education. Respir Care 2005;50(10):1360-1374; discussion 1374-1375.
    OpenUrlAbstract/FREE Full Text
Back to top

In this issue

 

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Related Articles

Cited By...

Keywords